Corbus Pharmaceuticals Holdings, Inc. (CRBP): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-30, first reflected in a filing dated 2023-03-07. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

13.32M
Year ended 2025-12-31
+47.3%
3-year compound annual growth
2021-12-31: 4.09M2022-12-31: 4.17M2023-12-31: 4.33M2024-12-31: 10.92M2025-12-31: 13.32M13.32M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3113.32M+22.0%2026-03-09, From 2025-01-01
2024-12-3110.92M+152.2%2026-03-09, From 2024-01-01
2023-12-314.33M+3.8%2025-03-11, From 2023-01-01
2022-12-314.17M+1.8%2024-03-12, From 2022-01-01
2021-12-314.09Mn/a2023-03-07, From 2021-01-01